72 related articles for article (PubMed ID: 26321665)
21. Ewing sarcoma.
Choi EY; Gardner JM; Lucas DR; McHugh JB; Patel RM
Semin Diagn Pathol; 2014 Jan; 31(1):39-47. PubMed ID: 24680181
[TBL] [Abstract][Full Text] [Related]
22. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.
Mackintosh C; García-Domínguez DJ; Ordóñez JL; Ginel-Picardo A; Smith PG; Sacristán MP; de Álava E
Oncogene; 2013 Mar; 32(11):1441-51. PubMed ID: 22641220
[TBL] [Abstract][Full Text] [Related]
23. Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors.
Anderson JL; Titz B; Akiyama R; Komisopoulou E; Park A; Tap WD; Graeber TG; Denny CT
Mol Cancer Res; 2014 Dec; 12(12):1740-54. PubMed ID: 25092916
[TBL] [Abstract][Full Text] [Related]
24. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
25. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
26. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.
Hauer K; Calzada-Wack J; Steiger K; Grunewald TG; Baumhoer D; Plehm S; Buch T; Prazeres da Costa O; Esposito I; Burdach S; Richter GH
Cancer Res; 2013 Jan; 73(2):967-77. PubMed ID: 23204234
[TBL] [Abstract][Full Text] [Related]
27. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
[TBL] [Abstract][Full Text] [Related]
28. Adamantinoma-like Ewing family tumor of soft tissue associated with the vagus nerve: a case report and review of the literature.
Kikuchi Y; Kishimoto T; Ota S; Kambe M; Yonemori Y; Chazono H; Yamasaki K; Ochiai H; Hiroshima K; Tanaka M; Tanaka Y; Horie H; Nakatani Y
Am J Surg Pathol; 2013 May; 37(5):772-9. PubMed ID: 23552387
[TBL] [Abstract][Full Text] [Related]
29. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
30. [Ewing/PNET sarcoma family of tumors: towards a new paradigm?].
Renard C; Ranchère-Vince D
Ann Pathol; 2015 Jan; 35(1):86-97. PubMed ID: 25534668
[TBL] [Abstract][Full Text] [Related]
31. A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanisms.
Picarda G; Surget S; Guiho R; Téletchéa S; Berreur M; Tirode F; Pellat-Deceunynck C; Heymann D; Trichet V; Rédini F
Mol Cancer Res; 2012 Mar; 10(3):336-46. PubMed ID: 22258765
[TBL] [Abstract][Full Text] [Related]
32. RNA-Seq reveals differentially expressed isoforms and novel splice variants in buccal mucosal cancer.
Jakhesara SJ; Koringa PG; Bhatt VD; Shah TM; Vangipuram S; Shah S; Joshi CG
Gene; 2013 Mar; 516(1):24-32. PubMed ID: 23266631
[TBL] [Abstract][Full Text] [Related]
33. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.
Sand LG; Berghuis D; Szuhai K; Hogendoorn PC
Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431
[TBL] [Abstract][Full Text] [Related]
34. Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.
Sand LG; Szuhai K; Hogendoorn PC
Int J Mol Sci; 2015 Jul; 16(7):16176-215. PubMed ID: 26193259
[TBL] [Abstract][Full Text] [Related]
35. Omic approaches to pediatric bone sarcomas.
Tirtei E; Cereda M; De Luna E; Quarello P; Asaftei SD; Fagioli F
Pediatr Blood Cancer; 2020 Feb; 67(2):e28072. PubMed ID: 31736201
[TBL] [Abstract][Full Text] [Related]
36. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis.
Mancarella C; Caldoni G; Ribolsi I; Parra A; Manara MC; Mercurio AM; Morrione A; Scotlandi K
Front Oncol; 2020; 10():994. PubMed ID: 32719743
[TBL] [Abstract][Full Text] [Related]
37. Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray.
Rahman FA; Aziz N; Coverley D
BMC Cancer; 2010 Sep; 10():482. PubMed ID: 20831784
[TBL] [Abstract][Full Text] [Related]
38. Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.
Poulain S; Roumier C; Venet-Caillault A; Figeac M; Herbaux C; Marot G; Doye E; Bertrand E; Geffroy S; Lepretre F; Nibourel O; Decambron A; Boyle EM; Renneville A; Tricot S; Daudignon A; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Clin Cancer Res; 2016 Mar; 22(6):1480-8. PubMed ID: 26490317
[TBL] [Abstract][Full Text] [Related]
39. Expression of multiple membrane-associated phospholipase A1 beta transcript variants and lysophosphatidic acid receptors in Ewing tumor cells.
Schmiedel BJ; Hutter C; Hesse M; Staege MS
Mol Biol Rep; 2011 Oct; 38(7):4619-28. PubMed ID: 21132378
[TBL] [Abstract][Full Text] [Related]
40. A pan-cancer analysis of alternative splicing events reveals novel tumor-associated splice variants of matriptase.
Dargahi D; Swayze RD; Yee L; Bergqvist PJ; Hedberg BJ; Heravi-Moussavi A; Dullaghan EM; Dercho R; An J; Babcook JS; Jones SJ
Cancer Inform; 2014; 13():167-77. PubMed ID: 25506199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]